Production (Stage)
Aprea Therapeutics, Inc.
APRE
$1.67
$0.010.60%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.85M | 26.25M | 28.69M | 32.37M | 21.61M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 726.30K | 234.20K | 865.10K | 698.90K | 914.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 23.58M | 26.48M | 29.56M | 33.07M | 22.52M |
|
|
|||||
| Total Current Assets | 23.58M | 26.48M | 29.56M | 33.07M | 22.52M |
| Net Property, Plant & Equipment | 81.50K | 87.00K | 92.40K | 90.20K | 88.40K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 321.80K | 323.20K | 312.40K | 41.00K | 40.70K |
| Total Assets | 23.98M | 26.89M | 29.96M | 33.20M | 22.65M |
|
|
|||||
| Total Accounts Payable | 1.35M | 1.15M | 964.30K | 1.32M | 1.67M |
| Total Accrued Expenses | 2.01M | 2.48M | 2.08M | 1.50M | 2.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 50.70K | 148.40K | 529.00K |
| Total Other Current Liabilities | -- | -- | 50.70K | 148.40K | 529.00K |
| Total Current Liabilities | 3.36M | 3.64M | 3.09M | 2.97M | 4.39M |
|
|
|||||
| Total Current Liabilities | 3.36M | 3.64M | 3.09M | 2.97M | 4.39M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.36M | 3.64M | 3.09M | 2.97M | 4.39M |
|
|
|||||
| Common Stock & APIC | 350.98M | 350.70M | 350.55M | 350.44M | 335.65M |
| Retained Earnings | -321.04M | -318.15M | -314.36M | -310.89M | -308.08M |
| Treasury Stock & Other | -10.63M | -10.60M | -10.63M | -10.63M | -10.61M |
| Total Common Equity | 19.31M | 21.95M | 25.56M | 28.92M | 16.95M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M |
|
|
|||||
| Total Common Equity | 19.31M | 21.95M | 25.56M | 28.92M | 16.95M |
| Total Preferred Equity | 1.31M | 1.31M | 1.31M | 1.31M | 1.31M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 20.62M | 23.26M | 26.87M | 30.23M | 18.26M |
|
|
|||||